Journal of Behavioral Medicine

, Volume 31, Issue 5, pp 445–451 | Cite as

Relationship of race-, sexual orientation-, and HIV-related discrimination with adherence to HIV treatment: a pilot study

  • Jessica M. Boarts
  • Laura M. Bogart
  • Melanie A. Tabak
  • Aaron P. Armelie
  • Douglas L. Delahanty


Adherence to highly active antiretroviral therapy (HAART) must be close to perfect in order to maintain suppression of HIV viral load, and to prevent the development of drug resistant strains of HIV. People living with HIV (PLWH) often report low levels of adherence. One variable that has been linked to poor adherence is perceived discrimination; however, research has generally not considered the possible unique effects of different types of discrimination on adherence. The present pilot study aimed to examine the association of three types of discrimination (due to HIV+ status, race, or sexual orientation) with adherence among 57 PLWH. Logistic regression analyses were conducted to demonstrate the relationships between each type of discrimination and self-reported adherence. Racial discrimination significantly predicted lower adherence levels, whereas sexual orientation- and HIV-related discrimination did not. Results underscore the importance of addressing discrimination issues, specifically racial, when designing interventions to improve adherence to HAART.


Discrimination Adherence HIV HAART 


  1. Ammassari, A., Antinori, A., Aloisi, M. S., Trotta, M. P., Murri, R., Bartoli, L., et al. (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics, 45, 394–402. doi:10.1176/appi.psy.45.5.394.PubMedCrossRefGoogle Scholar
  2. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Chesney, M. A., & Moss, A. (2001). Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior, 5, 275–281. doi:10.1023/A:1011396711486.CrossRefGoogle Scholar
  3. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS (London, England), 14, 357–366. doi:10.1097/00002030-200003100-00008.Google Scholar
  4. Bird, S. T., Bogart, L. M., & Delahanty, D. L. (2004). Health-related correlates of perceived discrimination in HIV care. AIDS Patient Care and STDs, 18, 19–26. doi:10.1089/108729104322740884.PubMedCrossRefGoogle Scholar
  5. Boarts, J. M., Sledjeski, E. M., Bogart, L. M., & Delahanty, D. L. (2006). The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS and Behavior, 10, 253–261. doi:10.1007/s10461-006-9069-7.PubMedCrossRefGoogle Scholar
  6. Bogart, L. M., Cowgill, B. O., Kennedy, D. K., Ryan, G., Murphy, D. A., Elijah, J., et al. (2008). HIV-related stigma among people with HIV and their families: A qualitative analysis. AIDS and Behavior, 12, 244–254. doi:10.1007/s10461-007-9231-x.PubMedCrossRefGoogle Scholar
  7. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255–266. doi:10.1080/09540120050042891.PubMedCrossRefGoogle Scholar
  8. Clark, R., Anderson, N. B., Clark, V. R., & Williams, D. R. (1999). Racism as a stressor for African Americans—A biopsychosocial model. The American Psychologist, 54, 805–816. doi:10.1037/0003-066X.54.10.805.PubMedCrossRefGoogle Scholar
  9. Cohen, M. A., Alfonso, C. A., Hoffman, R. G., Milau, V., & Carrera, G. (2001). The impact of PTSD on treatment adherence in persons with HIV infection. General Hospital Psychiatry, 23, 294–296. doi:10.1016/S0163-8343(01)00152-9.PubMedCrossRefGoogle Scholar
  10. Corrigan, P. W., & Penn, D. L. (1999). Lessons from social psychology on discrediting psychiatric stigma. American Psychologist, 54, 765–776.PubMedCrossRefGoogle Scholar
  11. Crocker, J., Major, B., & Steele, C. (1998). Social stigma. In D. T. Gilbert, S. T. Fiske, & G. Lindzey (Eds.), The handbook of social psychology (pp. 504–553). New York: McGraw-Hill.Google Scholar
  12. Elford, J., Ibrahim, F., Bukutu, C., & Anderson, J. (2008). HIV-related discrimination reported by people living with HIV in London, UK. AIDS and Behavior, 12, 255–264.PubMedCrossRefGoogle Scholar
  13. Feagin, J. R. (1991). The continuing significance of race: Antiblack discrimination in public places. American Sociological Review, 56, 101–116. doi:10.2307/2095676.CrossRefGoogle Scholar
  14. Fernando, S. (1984). Racism as a cause of depression. The International Journal of Social Psychiatry, 30, 41–49. doi:10.1177/002076408403000107.PubMedCrossRefGoogle Scholar
  15. French, T., Weiss, L., Waters, M., Tesoriero, J., Finkelstein, R., & Agins, B. (2005). Correlation of a brief perceived stress measure with nonadherence to antiretroviral therapy over time. Journal of Acquired Immune Deficiency Syndrome, 38, 590–597. doi:10.1097/01.qai.0000135960.88543.8d.CrossRefGoogle Scholar
  16. Gant, L. M., & Ostrow, D. G. (1995). Perceptions of social support and psychological adaptation to sexually acquired HIV among White and African American men. Social Work, 40, 215–224.Google Scholar
  17. Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Duran, R. E., Fernandez, M. I., McPherson-Baker, S., et al. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23, 413–418. doi:10.1037/0278-6133.23.4.413.PubMedCrossRefGoogle Scholar
  18. Gordillo, V., del Almo, J., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antretroviral therapy. AIDS (London, England), 13, 1763–1769. doi:10.1097/00002030-199909100-00021.Google Scholar
  19. Gostin, L. O., & Webber, D. W. (1998). The AIDS litigation project: HIV/AIDS in the courts in the1990s, part 2. AIDS and Public Policy Journal, 13, 3–19.PubMedGoogle Scholar
  20. Harris, R., Tobias, M., Jeffreys, M., Waldegrave, K., Karlsen, S., & Nazroo, J. (2006). Racism and health: The relationship between experience of racial discrimination and health in New Zealand. Social Science and Medicine, 63, 1428–1441. doi:10.1016/j.socscimed.2006.04.009.PubMedCrossRefGoogle Scholar
  21. Herek, G. M., & Capitanio, J. P. (1999). AIDS stigma and sexual prejudice. The American Behavioral Scientist, 42, 1130–1147.Google Scholar
  22. Huebner, D. M., Rebchook, G. M., & Kegeles, S. M. (2004). Experiences of harassment, discrimination, and physical violence among young gay and bisexual men. American Journal of Public Health, 94, 1200–1203.PubMedCrossRefGoogle Scholar
  23. Johnson, M. O., Catz, S. L., Remien, R. H., Rotheram-Borus, M. J., Morin, S. F., Charlebois, E., et al. (2003). Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the health living project. AIDS Patient Care and STDs, 17, 645–656. doi:10.1089/108729103771928708.PubMedCrossRefGoogle Scholar
  24. Johnson, M. O., Neilands, T. B., Dilworth, S. E., Morin, S. F., Remien, R. H., & Chesney, M. A. (2007). The role of self-efficacy in HIV treatment adherence: Validation of the HIV treatment adherence self-efficacy scale. Journal of Behavioral Medicine, 30, 359–370. doi:10.1007/s10865-007-9118-3.PubMedCrossRefGoogle Scholar
  25. Knobel, H., Guelar, A., Carmona, A., Espona, M., Gonzalez, A., Lopez-Colomes, J. L., et al. (2001). Virologic outcomes and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care and STDs, 15, 193–199. doi:10.1089/10872910151133729.PubMedCrossRefGoogle Scholar
  26. Landrine, H., & Klonoff, E. A. (1996). The schedule of racist events: A measure of racial discrimination and a study of its negative physical and mental health consequences. The Journal of Black Psychology, 22, 144–168. doi:10.1177/00957984960222002.CrossRefGoogle Scholar
  27. Low-Beer, S., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndrome, 23, 360–361.Google Scholar
  28. Lui, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.Google Scholar
  29. Lyon, D. E., & Truban, E. (2000). HIV-related lipodystrophy: A clinical syndrome with implications for nursing practice. JANAC: Journal of the Association of Nurses in AIDS Care, 11, 36–42.PubMedGoogle Scholar
  30. Major, B., & O’Brien, L. T. (2005). The social psychology of stigma. Annual Review of Psychology, 56, 393–421. doi:10.1146/annurev.psych.56.091103.070137.PubMedCrossRefGoogle Scholar
  31. Mays, V. M., & Cochran, S. D. (1987). Acquired immunodeficiency syndrome and black Americans: Special psychosocial issues. Public Health Reports, 102, 224–231.PubMedGoogle Scholar
  32. McNabb, J. J., Nicolau, D. P., Stoner, J. A., & Ross, J. (2003). Patterns of adherence to antiretroviral medications: The value of electronic monitoring. AIDS (London, England), 17, 1763–1767. doi:10.1097/00002030-200308150-00005.Google Scholar
  33. Mellins, C. A., Kang, E., Leu, C. S., Havens, J. F., & Chesney, M. A. (2003). Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs, 17, 407–416. doi:10.1089/108729103322277420.PubMedCrossRefGoogle Scholar
  34. Miller, M., Serner, M., & Wagner, M. (2005). Sexual diversity among black men who have sex with men in an inner-city community. Journal of Urban Health, 82, i26–i34. doi:10.1093/jurban/jti021.PubMedGoogle Scholar
  35. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMedGoogle Scholar
  36. Peretti-Watel, P., Spire, B., Pierret, J., Lert, F., Obadia, Y., & The Vespa Group. (2006). Management of HIV-related stigma and adherence to HAART: Evidence from a large representative sample of outpatients attending French hospitals. AIDS Care, 18, 254–261. doi:10.1080/09540120500456193.PubMedCrossRefGoogle Scholar
  37. Pradier, C., Carrieri, P., Bentz, L., Spire, B., Dellamonica, P., Moreau, J., et al. (2001). Impact of short-term adherence on virological and immunological success of HAART: A case study among French HIV-infected IDUs. International Journal of STD and AIDS, 12, 324–328. doi:10.1258/0956462011923165.PubMedCrossRefGoogle Scholar
  38. Radloff, L. S. (1977). The CES-D scale: A new self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401. doi:10.1177/014662167700100306.CrossRefGoogle Scholar
  39. Ricart, F., Cohen, M. A., Alfonso, C. A., Hoffman, R. G., Quinones, N., Cohen, A., et al. (2002). Understanding the psychodynamics of non-adherence to medical treatment in persons with HIV infection. General Hospital Psychiatry, 24, 176–180. doi:10.1016/S0163-8343(02)00172-X.PubMedCrossRefGoogle Scholar
  40. Roberts, K. J. (2000). Barriers to and facilitators of HIV-positive patients’ adherence to antiretroviral treatment regimens. AIDS Patient Care and STDs, 14, 155–168. doi:10.1089/108729100317948.PubMedCrossRefGoogle Scholar
  41. Safren, S. A., Gershuny, B. S., & Hendriksen, E. (2003). Symptoms of posttraumatic stress and death anxiety in persons with HIV and medication adherence difficulties. AIDS Patient Care and STDs, 17, 657–664. doi:10.1089/108729103771928717.PubMedCrossRefGoogle Scholar
  42. Safren, S. A., Otto, M. W., Worth, J. L., Salomon, E., Johnson, W., Mayer, K., et al. (2001). Two strategies to increase adherence to HIV antiretroviral medication: Life-steps and medication monitoring. Behaviour Research and Therapy, 39, 1151–1162. doi:10.1016/S0005-7967(00)00091-7.PubMedCrossRefGoogle Scholar
  43. Schuman, P., Ohmit, S. E., Cohen, M., Sacks, H. S., Richardson, J., Young, M., et al. (2001). Prescription of and adherence to antiretroviral therapy among women with AIDS. AIDS and Behavior, 5, 371–378. doi:10.1023/A:1013143024686.CrossRefGoogle Scholar
  44. Schuster, M. A., Collins, R., Cunningham, W. E., Morton, S. C., Zierler, S., Wong, M., et al. (2005). Perceived discrimination in clinical care in a nationally representative sample of HIV-infected adults receiving health care. Journal of General Internal Medicine, 20, 807–813. doi:10.1111/j.1525-1497.2005.05049.x.PubMedCrossRefGoogle Scholar
  45. Sellers, R. M., & Shelton, J. N. (2003). The role of racial identity in perceived racial discrimination. Journal of Personality and Social Psychology, 84, 1079–1092. doi:10.1037/0022-3514.84.5.1079.PubMedCrossRefGoogle Scholar
  46. Sethi, A. K., Celentano, D. D., Gange, S. J., Moore, R. D., & Gallant, J. E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37, 1112–1118. doi:10.1086/378301.PubMedCrossRefGoogle Scholar
  47. Sledjeski, E. M., Delahanty, D. L., & Bogart, L. M. (2005). Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4 counts in people living with HIV. AIDS Patient Care and STDs, 19, 26–34. doi:10.1089/apc.2005.19.728.CrossRefGoogle Scholar
  48. Smedley, B. D., Stith, A. Y., & Nelson, A. R. (2003). Unequal treatment: Confronting racial and ethnic disparities in health care. Washington, DC: National Academies Press, Institute of Medicine.Google Scholar
  49. Stokes, J. P., Vanable, P. A., & McKirnan, D. J. (1996). Ethnic differences in sexual behavior, condom use, and psychosocial variables among African American and White men who have sex with men. Journal of Sex Research, 33, 373–381.CrossRefGoogle Scholar
  50. Taylor, S. E., Repetti, R. L., & Seeman, T. (1997). Health psychology: What is an unhealthy environment and how does it get under the skin? Annual Review of Psychology, 48, 411–447. doi:10.1146/annurev.psych.48.1.411.PubMedCrossRefGoogle Scholar
  51. Wagner, G. J., & Ghosh-Dastidar, B. (2002). Electronic monitoring: Adherence assessment or intervention? HIV Clinical Trials, 3, 45–51. doi:10.1310/XGXU-FUDK-A9QT-MPTF.PubMedCrossRefGoogle Scholar
  52. Weiner, B., Perry, R. P., & Magnusson, J. (1988). An attributional analysis of reactions to stigma. Journal of Personality and Social Psychology, 55, 738–748. doi:10.1037/0022-3514.55.5.738.PubMedCrossRefGoogle Scholar
  53. Wingood, G. M., DiClemente, R. J., Mikhail, I., McCree, D. H., Davies, S. L., Hardin, J. W., et al. (2007). HIV discrimination and the health of women living with HIV. Women and Health, 46, 99–112. doi:10.1300/J013v46n02_07.Google Scholar
  54. Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139, 810–816.PubMedGoogle Scholar
  55. Zucker, A. N., & Landry, L. J. (2007). Embodied discrimination: The relation of sexism and distress to women’s drinking and smoking behaviors. Sex Roles, 56, 193–203. doi:10.1007/s11199-006-9163-3.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Jessica M. Boarts
    • 1
  • Laura M. Bogart
    • 2
  • Melanie A. Tabak
    • 1
  • Aaron P. Armelie
    • 1
  • Douglas L. Delahanty
    • 1
    • 3
  1. 1.Department of PsychologyKent State UniversityKentUSA
  2. 2.RAND CorporationSanta MonicaUSA
  3. 3.Department of Psychology in PsychiatryNortheastern Ohio Universities College of Medicine (NEOUCOM)RootstownUSA

Personalised recommendations